# A Study of SGB-9768 in Adult Healthy Volunteers

> **NCT06501573** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Suzhou Sanegene Bio Inc.** · enrollment: 37 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** SGB-9768
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06501573
- **Lead sponsor:** Suzhou Sanegene Bio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-06
- **Primary completion:** 2025-05-03
- **Final completion:** 2025-10-17
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06501573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06501573, "A Study of SGB-9768 in Adult Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06501573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*